Kao SJ - Search Results

1

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.

Chang HJ, Ko HL, Lee CY, Wu RH, Yeh YW, Jiang JS, Kao SJ, Chi KH. Chang HJ, et al. Among authors: kao sj. Radiat Oncol. 2012 Dec 27;7:222. doi: 10.1186/1748-717X-7-222. Radiat Oncol. 2012. PMID: 23268786 Free PMC article.

2

Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: a mono-institutional experience.

Chang CC, Chi KH, Kao SJ, Hsu PS, Tsang YW, Chang HJ, Yeh YW, Hsieh YS, Jiang JS. Chang CC, et al. Among authors: kao sj. Lung Cancer. 2011 Aug;73(2):189-94. doi: 10.1016/j.lungcan.2010.12.007. Epub 2011 Jan 17. Lung Cancer. 2011. PMID: 21247653 Clinical Trial.

3

Improving radioresponse through modification of the tumor immunological microenvironment.

Chi KH, Wang YS, Kao SJ. Chi KH, et al. Among authors: kao sj. Cancer Biother Radiopharm. 2012 Feb;27(1):6-11. doi: 10.1089/cbr.2011.1048. Epub 2012 Jan 12. Cancer Biother Radiopharm. 2012. PMID: 22239431 Review.

4

Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.

Chi KH, Ko HL, Yang KL, Lee CY, Chi MS, Kao SJ. Chi KH, et al. Among authors: kao sj. Oncotarget. 2015 Jun 30;6(18):16735-45. doi: 10.18632/oncotarget.3793. Oncotarget. 2015. PMID: 25944689 Free PMC article.

5

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial.

Ko HL, Wang YS, Fong WL, Chi MS, Chi KH, Kao SJ. Ko HL, et al. Among authors: kao sj. Thorac Cancer. 2014 Nov;5(6):500-8. doi: 10.1111/1759-7714.12117. Epub 2014 Oct 23. Thorac Cancer. 2014. PMID: 26767044 Free PMC article.

6

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Yang KL, Chang YC, Ko HL, Chi MS, Wang HE, Hsu PS, Lin CC, Yeh DY, Kao SJ, Jiang JS, Chi KH. Yang KL, et al. Among authors: kao sj. Clin Lung Cancer. 2016 Nov;17(6):550-557. doi: 10.1016/j.cllc.2016.05.013. Epub 2016 Jun 8. Clin Lung Cancer. 2016. PMID: 27378175 Clinical Trial.

7

Real-world outcomes of first- and second-generation tyrosine kinase inhibitors first-line in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: A retrospective observational cohort study.

Ng WW, Lin CC, Cheng CY, Jiang JS, Kao SJ, Yeh DY. Ng WW, et al. Among authors: kao sj. PLoS One. 2021 Jun 24;16(6):e0253335. doi: 10.1371/journal.pone.0253335. eCollection 2021. PLoS One. 2021. PMID: 34166400 Free PMC article.

8

Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process.

Hsu PS, Wang YS, Huang SC, Lin YH, Chang CC, Tsang YW, Jiang JS, Kao SJ, Uen WC, Chi KH. Hsu PS, et al. Among authors: kao sj. Proteome Sci. 2011 Apr 17;9(1):20. doi: 10.1186/1477-5956-9-20. Proteome Sci. 2011. PMID: 21496334 Free PMC article.

9

Respiratory management after self-extubation.

Jiang JS, Kao SJ, Lin CM, Yeh YW. Jiang JS, et al. Among authors: kao sj. J Formos Med Assoc. 2000 Sep;99(9):689-92. J Formos Med Assoc. 2000. PMID: 11000731

10

Effect of early application of biphasic positive airway pressure on the outcome of extubation in ventilator weaning.

Jiang JS, Kao SJ, Wang SN. Jiang JS, et al. Among authors: kao sj. Respirology. 1999 Jun;4(2):161-5. doi: 10.1046/j.1440-1843.1999.00168.x. Respirology. 1999. PMID: 10382235 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters